These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11289569)

  • 1. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: urologic and cardiovascular implications.
    Nehra A; Colreavy F; Khandheria BK; Chandrasekaran K
    World J Urol; 2001 Feb; 19(1):40-5. PubMed ID: 11289569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.
    Corbin JD; Francis SH; Webb DJ
    Urology; 2002 Sep; 60(2 Suppl 2):4-11. PubMed ID: 12414329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells.
    Moreland RB; Goldstein I; Traish A
    Life Sci; 1998; 62(20):PL 309-18. PubMed ID: 9600334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor:
    Moreland RB; Goldstein I; Kim NN; Traish A
    Trends Endocrinol Metab; 1999 Apr; 10(3):97-104. PubMed ID: 10322402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle.
    Park K; Moreland RB; Goldstein I; Atala A; Traish A
    Biochem Biophys Res Commun; 1998 Aug; 249(3):612-7. PubMed ID: 9731184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil: a 4-year update in the treatment of 20 million erectile dysfunction patients.
    Carson CC
    Curr Urol Rep; 2003 Dec; 4(6):488-96. PubMed ID: 14622503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
    Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
    Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sildenafil on non-adrenergic non-cholinergic neurotransmission in bovine penile small arteries.
    Simonsen U; Contreras J; García-Sacristán A; Martinez AC
    Eur J Pharmacol; 2001 Jan; 412(2):155-69. PubMed ID: 11165227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.
    Wallis RM; Corbin JD; Francis SH; Ellis P
    Am J Cardiol; 1999 Mar; 83(5A):3C-12C. PubMed ID: 10078537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Deho' F; Zanni G; Barbieri L; Rigatti P; Montorsi F
    World J Urol; 2005 Dec; 23(6):374-84. PubMed ID: 16273417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of phosphodiesterase 5 inhibition in erectile dysfunction.
    Rosen RC; Kostis JB
    Am J Cardiol; 2003 Nov; 92(9A):9M-18M. PubMed ID: 14609619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological profiles of sildenafil (VIAGRA) in the treatment of erectile dysfunction: efficacy and drug interaction with nitrate].
    Omote M
    Nihon Yakurigaku Zasshi; 1999 Oct; 114(4):213-8. PubMed ID: 10584234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall cardiovascular profile of sildenafil citrate.
    Zusman RM; Morales A; Glasser DB; Osterloh IH
    Am J Cardiol; 1999 Mar; 83(5A):35C-44C. PubMed ID: 10078541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.
    Ballard SA; Gingell CJ; Tang K; Turner LA; Price ME; Naylor AM
    J Urol; 1998 Jun; 159(6):2164-71. PubMed ID: 9598563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
    Corbin JD
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S4-7. PubMed ID: 15224127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE gene I/D and NOS3 G894T polymorphisms and response to sildenafil in men with erectile dysfunction.
    Eisenhardt A; Sperling H; Hauck E; Porst H; Stief C; Rübben H; Müller N; Siffert W
    Urology; 2003 Jul; 62(1):152-7. PubMed ID: 12837457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds.
    Turko IV; Ballard SA; Francis SH; Corbin JD
    Mol Pharmacol; 1999 Jul; 56(1):124-30. PubMed ID: 10385692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erectile dysfunction: an update on new therapeutic options].
    Roumeguère T
    Acta Urol Belg; 2000; 68(2):41-2. PubMed ID: 11098588
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F; Longhurst PA; White MD
    BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxation effect of nitric oxide-donor on diabetic penile smooth muscle in vitro.
    Taher A; Birowo P; Kamil ST; Shahab N
    Clin Hemorheol Microcirc; 2000; 23(2-4):277-81. PubMed ID: 11321451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.